Heart Failure

This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congestive heart failure (CHF). The channel includes news on HFpEF and HFrEF. Heart failure occurs when the heart is no longer able to pump as much blood as the body requires. This can lead to enlargement of the heart because the muscle works harder to supply blood, but the pumping is ineffective. This may be due to defects in the myocardium, such as an infarct, or due to structural issues such as severe valve regurgitation. The disease is divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant  or a left ventricular assist device (LVAD).

Primary tabs View(active tab) Edit Delete Revisions Entityqueue Devel Open configuration options Open configuration options Videos | Venous Therapies | June 27, 2017 VIDEO: How the Ekos Thrombolytic Technology Works to Dissolve Clots Open Related Chest Pain Imaging Content: configuration options Venous Thrombolytic System Demonstration Play Mute Remaining Time -3:23 Picture-in-Picture Fullscreen This video, provided by Ekos, demonstrates the EkoSonic endovascular System thrombolytic system to treat dee
Feature | Cardiovascular Business
Top 10 Cardiology Videos on DAIC for April

Here are the top 10 performing videos on the Diagnostic and Interventional Cardiology (DAIC) website during the month of ...

Home May 09, 2022
Home
Heart failure patients implanted with Barostim can now receive conditional MRI scans
News | Magnetic Resonance Imaging (MRI)
CVRx Receives MR-conditional Labeling Approval for its Barostim Heart Failure System

May 9, 2022 — CVRx, Inc., developer of the world’s first FDA-approved neuromodulation device to treat the symptoms of ...

Home May 09, 2022
Home
The trends of an increased interest in RPM and potential cost savings have inspired companies to participate in this slowly evolving paradigm shift and improve technology
Feature | Patient Monitors | By Amit Shah, MD, MSCR
Use and Benefits of RPM in a Clinical Setting

I work at Emory University in a multidisciplinary group that is employing medical technologies to improve our ...

Home May 05, 2022
Home
Results from the DELIVER and DAPA-HF Phase III trials demonstrate FARXIGA’s efficacy in heart failure regardless of ejection fraction
News | Cardiovascular Clinical Studies
FARXIGA Met Primary Endpoint in DELIVER Phase III Trial

May 5, 2022 — High-level results from the DELIVER Phase III trial showed AstraZeneca’s FARXIGA (dapagliflozin) reached a ...

Home May 05, 2022
Home
Woman experiencing chest pains
News | Sudden Cardiac Arrest
Surprising Risk Factors may Predict Heart Attacks in Young Women

May 5, 2022 – A new Yale-led study has for the first time identified which risk factors are more likely to trigger a ...

Home May 05, 2022
Home
Blood cells travelling in vessel
News | Heart Failure
Study Reveals how Blood Vessels use “Short Cuts” to Control the Cardiovascular System

May 5, 2022 – Cardiovascular disease is a group of conditions that can arise from a lack of physical activity, poor diet ...

Home May 05, 2022
Home
. Leading the charge are devices like the Eko smart stethoscope and the Tyto remote otoscope that allow clinicians to remotely auscultate patients’ hearts, lungs and abdomen, and see inside the ear. More devices will surely come, with the aim of replicating the in-office visit.
Feature | Cardiac Diagnostics | By Adam Saltman, MD, PhD
The Future of Cardiac Health

Before opining on the future of cardiac health, I think it’s important to define what “cardiac health” actually is. If ...

Home May 04, 2022
Home
With the increase of patients experiencing heart failure and clinical challenges to manage advanced heart failure conditions, therapies with implantable devices have become an essential treatment method
Feature | Heart Failure | By Jean-Luc Boulnois, Ph.D.
Effectively Treating Heart Failure: New Technology on the Horizon

The current standard of care for heart failure (HF) is guideline-directed medical therapy combined with device-based ...

Home May 04, 2022
Home
3D illustration of an mRNA strand
News | Cardiac Rehabilitation
COVID-19 Vaccine Technique Shows Promise for Heart Disease

May 2, 2022 – A method for delivering genetic material to the body is being tested as a way to repair damaged heart ...

Home May 02, 2022
Home
Heart cells
News | Congenital Heart
Scientists Implicate Non-cardiac Genes in Congenital Heart Disease

May 2, 2022 – Inside embryonic cells, specific proteins control the rate at which genetic information is transcribed ...

Home May 02, 2022
Home
Image of late comedian Gilbert Gottfried from Wikipedia
Feature | Cardiovascular Business | By Melinda Taschetta-Millane
Top 10: What Viewers Were Reading in April 2022

Here is what you and your colleagues found to be most interesting in the field of cardiology during the month of April ...

Home May 02, 2022
Home
The U.S. Food and Drug Administration (FDA) is alerting healthcare providers to the possibility that patients who have the Medtronic Heartware Ventricular Assist Device (HVAD) System and appear to present with pump thrombosis may have a welding defect in the internal pump causing the pump to malfunction.
News | Ventricular Assist Devices (VAD)
FDA Alert: Potential for Internal Pump Malfunction in the Medtronic HVAD System

April 28, 2022 — The U.S. Food and Drug Administration (FDA) is alerting healthcare providers to the possibility that ...

Home April 28, 2022
Home
Aspirin therapy, as opposed to statin use, for non-obstructive coronary artery disease does not reduce major cardiovascular events, according to a new study published in the journal Radiology: Cardiothoracic Imaging.
News | CT Angiography (CTA)
Aspirin Does Not Cut Risk in Non-Obstructive Coronary Artery Disease

April 28, 2022 — Aspirin therapy, as opposed to statin use, for non-obstructive coronary artery disease does not reduce ...

Home April 28, 2022
Home
This ERC Advanced Grant is awarded to scientists with more than ten years of research experience who have already played a prominent role in their field.
News | Heart Failure
MDC Receives ERC Advanced Grant for Cardiac Research

April 27, 2022 – The contractile and elastic properties of the heart are finely tuned. This is a prerequisite for the ...

Home April 27, 2022
Home
The U.S. Preventive Services Task Force (USPSTF) has released its final recommendations on low-dose aspirin therapy for the primary prevention of cardiovascular disease in adults
News | Stroke
New USPSTF Guidance: Continue to Take Low-Dose Aspirin if you have a History of Heart Attack, AFib, Stroke or Vascular Stenting

April 27, 2022 – The U.S. Preventive Services Task Force (USPSTF) has released its final recommendations on low-dose asp ...

Home April 27, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now